9 Reporting in Brachytherapy: Dose and Volume Specification

192 Reporting in Brachytherapy

Fig 6.20 Reporting Intraluminal Brachytherapy (continued 2) Fig 6.20F:

Prescription and reporting point are identical at 5 mm from the Applicator Surface

Fig 6.20G: Prescription and reporting point are not identical: Prescription point is at 3 mm from the Applicator Surface (depth of the vaginal wall), Reference Point remains at 5 mm from the AS

Fig 6.20H: Prescription different at the vaginal vault (at 10 mm from the AS) and along the vaginal wall (at 5 mm from the AS). Reporting at 5 mm for the vaginal wall and at 10 mm for the vaginal vault.

Fig 6.20F-H Reporting in Endovaginal Brachytherapy Dose Reporting for a given Applicator Diameter (AD) for different prescription practice. Prescription Depth and Prescribed Dose (PD); Reference Depth (RD), Reference Volume Length (RVL), Active Source Length (ASL). Reference volume width (RVW) and thickness (RVT) are not in the diagram.